This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Postmenopausal Osteoporosis
and you are
over 45
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of the study is to assess the relative antiresorptive properties of 2 osteoporosis medications when combined with teriparatide.

Provided treatments

  • Drug: Teriparatide 40-mcg subcutaneous injection
  • Drug: Denosumab Injection
  • Drug: Alendronate Oral Tablet

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01750086. The sponsor of the trial is Massachusetts General Hospital and it is looking for 27 volunteers for the current phase.
Official trial title:
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption